Related Experiment Video
Updated: Jun 10, 2026
07:42
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
Oxaliplatin-induced acute thrombocytopenia.
Jessica M Mason1, Gareth Jg Rees
1Bristol Haematology and Oncology Centre, Horfield Road, Bristol, BS2 8ED, UK.
Summary
Severe thrombocytopenia, a hypersensitivity reaction to oxaliplatin, can occur unexpectedly even after prior uncomplicated exposure. Vigilance for unusual acute symptoms during or after oxaliplatin infusion is crucial for patient safety.
Area of Science:
- Oncology
- Hematology
- Clinical Pharmacology
Background:
- Oxaliplatin is a widely used chemotherapy agent for colorectal cancer.
- Hypersensitivity reactions to chemotherapy can manifest in various ways.
- Acute hematological toxicities require prompt recognition and management.
Observation:
- A patient developed severe, immediate-onset thrombocytopenia during oxaliplatin treatment.
- This reaction occurred despite substantial prior uncomplicated exposure to oxaliplatin.
- The thrombocytopenia was consistent with a hypersensitivity reaction.
Findings:
- Oxaliplatin can induce severe acute hematological toxicity, specifically thrombocytopenia.
- Hypersensitivity reactions to oxaliplatin may present with delayed or unexpected onset.
- Previous uneventful exposures do not preclude subsequent severe reactions.
Implications:
- Healthcare providers must maintain high vigilance for unusual acute symptoms during oxaliplatin therapy.
- Early identification of hypersensitivity reactions is critical for patient safety.
- Consideration of alternative treatment strategies may be necessary for patients experiencing severe hypersensitivity.
Related Concept Videos
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...